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Childhood cancer is relatively rare, comprising less than 1% of 
cases of malignant disease.1 Cancer is the second most common 
cause of death in children in Western countries, while in Africa it 
is not even ranked among the 10 most common causes of death. 
Infections, nutritional disease, HIV and tuberculosis remain 
the most important paediatric health problems in developing 
countries. In developed countries, more than 80% of children with 
malignancies can be cured, but unfortunately most children with 
cancer live in developing countries, where the cure rate is much 
lower.2 In 2009 South Africa’s population was approximately 49 
million, of whom 15 500 000 were in the age group 0 - 14 years.3 
This translates to over 31% of the population, while in the USA 
and Western Europe the corresponding figures are 20%4 and 17%,5 
respectively. 
There is a need to understand malignant disease in children to find 
more efficient ways of treating it. Such a task is usually approached 
at four different levels: (i) the molecular and sub-molecular level 
(biochemistry, cell biology, immunology and genetics); (ii) the 
tissular or organ level (pathology); (iii) the patient level (clinical 
medicine); and (iv) the population level (epidemiology – factors 
that govern the occurrence and distribution of a disease in a 
given population).6 The combined data thus obtained create a 
comprehensive picture of the disease, leading to more effective 
prevention and cure.
Contribution of epidemiology to 
prevention and cure 
This contribution is considerable and manifests at many levels. 
Firstly, descriptive epidemiology focuses on the characteristics of 
the population affected by a given malignancy, such as age group, 
geographical distribution, sex and ethnicity. It provides information 
on the incidence and mortality of a given cancer over years, enabling 
the assessment of efficacy of various therapeutic interventions. It 
also identifies new syndromes and risk factors for known diseases. 
For example, by establishing that acute lymphoblastic leukaemia 
(ALL) is the most frequent cancer in childhood (up to 25% of all 
cancers),7 the study indicated that research of the causes, diagnosis 
and cure would lead to major gains by reducing the burden of 
malignant disease in children. However, epidemiological studies 
have found that in parts of Central Africa the most commonly 
encountered childhood cancer is not ALL, but Burkitt’s lymphoma, 
constituting almost 50% of all malignancies in children.8 Therefore, 
in that geographical area, targeting Burkitt’s lymphoma instead of 
ALL would be more effective in terms of population health.  
Analytical epidemiology tests hypotheses formulated on the basis 
of descriptive studies. It mainly compares a population group with 
exposure to a hypothetical risk factor with an unexposed group, 
and measures the incidence and prevalence of disease in both. 
Consequently it determines the strength of the influence of the risk 
factor studied. Another analytical method consists of following 
up cohorts of people in time, noting the incidence of the disease 
studied and the exposure to various potential risk factors. 
Epidemiological studies have contributed to understanding that 
most childhood cancers originate in the genetic make-up of the 
embryo or in utero. The occurrence of retinoblastoma, for example, 
was described in families and led to the discovery of its origin in 
a mutation of the RB1 tumour suppressor gene.9 Retinoblastoma 
constitutes about 3% of all cancers in children. Another typical 
example of an intrauterine event leading to childhood cancer is 
fetal exposure to diethylstilboestrol, which was prescribed for 3 
decades during the last century to prevent fetal loss. Girls born 
to the mothers who had been on this drug developed clear cell 
carcinomas of the vagina and uterine cervix.  An epidemiological 
study10 highlighted the high risk of cancer in women exposed to 
diethylstilboestrol in utero, leading to contraindication of the drug 
during pregnancy. Other risk factors for early childhood cancer 
have also been identified by epidemiological methods, e.g. infection 
with the Epstein-Barr virus that causes Burkitt’s lymphoma.
The analysis of cancer survival data provides important insight 
into the effectiveness of various therapeutic protocols. An equally 
important field where epidemiological methods are applied is 
the study of survivors of childhood cancer, e.g. with high rates of 
secondary malignancies, organ failure and infertility.11 
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Data sources 
Epidemiological studies use complex 
statistical calculations to test the correlation 
of phenomena observed in populations. 
Primary sources can be divided into 
population data and disease data. Population 
data for epidemiological research in South 
Africa are provided by Statistics South 
Africa, a governmental organisation.  The 
South African Children’s Tumour Registry 
incorporates information on malignant 
disease. It was started in 1987 as an initiative 
of the South African Children’s Cancer 
Study Group (SACCSG) and is the result 
of collaboration of all paediatric oncology 
units in the country. While the data are 
presented regularly at conferences and 
congresses, only a small section has been 
published.12 To my knowledge there is no 
other dedicated children’s cancer registry 
in Africa, although the International 
Association of Cancer Registries has 60 
African members.13 However, only 17 
of these are national registries and the 
remainder are regional or hospital records. 
These records include both children 
and adults with cancer; therefore some 
meaningful data pertaining only to children 
may be missed. 
The South African Children’s Tumour 
Registry is a central repository of data 
provided by individual, hospital-based 
registries in the country. While such 
registries record data on all patients 
presenting to paediatric oncology services, 
children who died without being seen 
at a hospital, as well as those treated by 
private oncologists or other paediatric 
sub-specialists, e.g. neurosurgeons, may 
not be recorded. Therefore, by its very 
nature, a central registry of hospital-
based registries cannot be complete. It 
is nevertheless the most efficient and 
sustainable way of obtaining data that can 
be used in statistical research, because it 
does not require substantial expenditure. 
The minimum data that can be collected in 
a hospital-based registry are: demographic 
information (name, age, sex, address), 
tumour type, localisation and stage, 
histological type, treatment and outcome, 
and yearly follow-up results. Should the 
patient die, the date and cause of death 
must be recorded.14
There are plans for starting a national 
registry, maintained by the Department 
of Health, in which childhood cancer 
data can be reported by following a 
more comprehensive procedure, e.g. by 
designating cancer as a notifiable disease. 
Such a measure would result in more 
accurate reporting; however, data collected 
would remain hospital based. 
An alternative source of cancer information 
is the National Cancer Registry, a 
pathology-based registry of the National 
Health Laboratory Service. However, this 
source  has several shortcomings with 
regard to children’s cancer: an unknown 
number of cases were not registered as they 
were diagnosed only clinically, sometimes 
assisted by identifying tumour markers 
in serum (e.g. hepatocellular carcinoma); 
children are on the same register as adults 
(as mentioned above, child-specific data 
may be missed); some clinical data were 
not communicated to the laboratories; and 
many laboratories decided to discontinue 
contributing to the register for fear of 
consequences arising from disclosing 
information that may be private.15  
A population-based registry would 
be closer to accurately reflecting the 
occurrence of malignant disease. To 
compile accurate data, patients for such 
a registry should be actively sought. 
Registrars should contact departments of 
pathology, departments of radiology that 
incorporate radiotherapy, other hospital 
departments (e.g. surgery), chemical 
pathology and haematology laboratories, 
outpatient and private clinics, and 
laboratories. They should also study death 
certificates and by the means described 
above identify cases of cancer, extracting 
and entering the data in the registry.16
Currently, however, the South African 
Children’s Tumour Registry remains 
the main source of statistical data for 
epidemiological studies in this particular 
field.
The objectives of the Children’s Tumour 
Registry are the following: to accurately 
present age-specific incidences, the 
relative frequencies of various neoplasms, 
the prevalence of children’s cancer and 
individual malignancies, and their 
distribution according to age, sex, 
ethnicity and geographical area. It also 
assesses subtype, stage and outcome of 
malignancies. The information collected 
has the potential to assist scientific analysis, 
planning and research. 
Table I is a synopsis of the number of 
childhood cancers recorded in the South 
African Children’s Tumour Registry from 
1997 to 2007 by year and type of tumour.
The annual incidence of tumours in South 
African children aged 0 - 14 years varied 
between 33.4 and 47.2 per million from 
2003 to 2007, much lower than in the USA 
or Europe. In Europe, for example, the 
annual incidence of cancer in this age group 
was 140 per million in 1990, increasing by 
1% per year for the last 3 decades.1 The 
explanation for this discrepancy is either 
non-diagnosis or lack of reporting.
In South Africa leukaemia is the most 
common malignancy in childhood, 
representing 25.35% of all cancers, which 
is similar to rates in other countries. While 
brain tumours and leukaemia comprise 
almost half of childhood malignancies in 
developed countries, in South Africa brain 
tumours represent only 13.44% of the total 




formulated on the 
basis of descriptive 
studies. 
table i. registered cases in the Children’s tumour registry, 1997 - 2007
  1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 total
Leukaemia 146 157 142 177 162 140 162 208 154 139 150 1 737
Lymphoma 69 83 66 98 85 83 88 86 98 78 89 923
Brain 62 61 100 78 80 85 106 104 94 82 69 921
Nephroblastoma 64 85 75 84 104 62 72 94 71 73 61 845
Neuroblastoma 38 25 37 44 29 30 27 41 29 31 41 372
Retinoblastoma 40 44 35 55 46 41 42 42 57 52 33 487
Liver 12 7 13 17 17 14 12 8 13 14 16 143
Soft-tissue sarcomas 58 59 44 73 54 65 64 73 65 43 53 651
Bone 22 25 20 22 26 31 25 28 34 48 28 309
Germ cell 20 27 27 24 20 21 20 17 19 15 13 223
Other 15 19 16 44 25 26 22 22 16 19 15 239
   Total 546 592 575 716 648 598 640 723 650 594 568 6 850
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substantial underreporting, the difference 
in incidence of this form of cancer between 
South Africa and much of the developed 
world is remarkable.
These simple calculations illustrate 
the utility of the cancer registry in the 
national effort to improve the health of 
the population. For example, the registry 
data confirmed that in South Africa, as 
in many other countries, the efforts to 
prevent, diagnose and treat leukaemia 
more effectively would lead to a substantial 
reduction in the cancer risk in children.
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In a nutshell
•    Childhood cancer is a relatively rare disease, comprising less than 1% of total cancers.
•    Childhood cancer is the second most common cause of death in children in First World coun-
tries. 
•    Eighty per cent of all childhood cancers occur in developing countries where the survival rate 
is low. 
•    Childhood cancers can be cured in more than 80% of cases in developed countries. 
•    A tumour registry is an essential tool for obtaining information about age-specific incidences, 
relative frequencies of various neoplasms, prevalence of children’s cancer and individual malig-
nancies and their distribution according to age, sex, ethnicity and geographical area.
•    Epidemiological studies of cancer include factors affecting the incidence and prevalence of the 
disease as a way to infer possible trends and causes. Most childhood cancers are due to genetic 
defects or intrauterine exposure to oncogenic factors.
•    The South African Children’s Tumour Registry was established in 1987 at the initiative of SACCSG 
and is the only one in Africa dedicated exclusively to childhood cancer.
•    Leukaemia is the most common malignancy diagnosed in children. 
•    Childhood cancer is significantly underreported in South Africa. 
